REL and lymphoma: In vitro knockdown of c-Rel in human HL cell lines [148] as well as in mouse WEHI-231 lymphoma cells [149] impaired cellular expansion, thus providing evidence for a therapeutic effect of c-Rel inhibition in lymphoma.